Proteomic differential display identifies upregulated vinculin as a possible biomarker of pancreatic cancer

  • Authors:
    • Yufeng Wang
    • Yasuhiro Kuramitsu
    • Tomio Ueno
    • Nobuaki Suzuki
    • Shigefumi Yoshino
    • Norio Iizuka
    • Xiulian Zhang
    • Junko Akada
    • Masaaki Oka
    • Kazuyuki Nakamura
  • View Affiliations

  • Published online on: August 30, 2012     https://doi.org/10.3892/or.2012.2004
  • Pages: 1845-1850
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pancreatic cancer (PC) is characterized by rapid tumor spread, and very few patients with PC survive for more than 5 years. It is imperative to discover additional diagnostic biomarkers or specific therapeutic targets in order to improve the treatment of patients with PC. In search for useful biomarkers, we analyzed ten pairs of non-cancerous and cancer tissues from patients with PC by two-dimensional gel electrophoresis (2-DE). Nineteen protein spots showed differential expression on 2-DE gels between the cancer and non-cancerous tissues. Six upregulated protein spots were identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS) as calreticulin, glutathione synthetase, stathmin, vinculin, α-enolase and glyceraldehyde-3-phosphate dehydrogenase. Western blotting demonstrated that vinculin was predominantly expressed in the pancreatic cancer tissues compared with to non-cancerous tissues. Our findings indicate that vinculin may be a clinically useful biomarker of PC.
View Figures
View References

Related Articles

Journal Cover

November 2012
Volume 28 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Wang, Y., Kuramitsu, Y., Ueno, T., Suzuki, N., Yoshino, S., Iizuka, N. ... Nakamura, K. (2012). Proteomic differential display identifies upregulated vinculin as a possible biomarker of pancreatic cancer. Oncology Reports, 28, 1845-1850. https://doi.org/10.3892/or.2012.2004
MLA
Wang, Y., Kuramitsu, Y., Ueno, T., Suzuki, N., Yoshino, S., Iizuka, N., Zhang, X., Akada, J., Oka, M., Nakamura, K."Proteomic differential display identifies upregulated vinculin as a possible biomarker of pancreatic cancer". Oncology Reports 28.5 (2012): 1845-1850.
Chicago
Wang, Y., Kuramitsu, Y., Ueno, T., Suzuki, N., Yoshino, S., Iizuka, N., Zhang, X., Akada, J., Oka, M., Nakamura, K."Proteomic differential display identifies upregulated vinculin as a possible biomarker of pancreatic cancer". Oncology Reports 28, no. 5 (2012): 1845-1850. https://doi.org/10.3892/or.2012.2004